Correlation Between Recursion Pharmaceuticals and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Nuvectis Pharma, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Nuvectis Pharma.
Diversification Opportunities for Recursion Pharmaceuticals and Nuvectis Pharma
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Recursion and Nuvectis is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and Nuvectis Pharma
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 0.7 times more return on investment than Nuvectis Pharma. However, Recursion Pharmaceuticals is 1.42 times less risky than Nuvectis Pharma. It trades about 0.03 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about 0.0 per unit of risk. If you would invest 717.00 in Recursion Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of 7.00 from holding Recursion Pharmaceuticals or generate 0.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Recursion Pharmaceuticals vs. Nuvectis Pharma
Performance |
| Timeline |
| Recursion Pharmaceuticals |
| Nuvectis Pharma |
Recursion Pharmaceuticals and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Recursion Pharmaceuticals and Nuvectis Pharma
The main advantage of trading using opposite Recursion Pharmaceuticals and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
| Nuvectis Pharma vs. Fate Therapeutics | Nuvectis Pharma vs. Caribou Biosciences | Nuvectis Pharma vs. Karyopharm Therapeutics | Nuvectis Pharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |